arrow
C

Cristina Gurizzan

Humanitas Research Hospital
H指数:12
被引数:485

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A multicenter retrospective analysis of recurrent/metastatic nasopharyngeal cancer from non-endemic areas: results in the pre-immunotherapy era

非流行区复发性/转移性鼻咽癌的多中心回顾性分析:免疫治疗时代前的结果

2025-09-020
PRE
The interplay of hypoxia, inflammation, and microbiota as indicators of malignant transformation in oral potentially malignant disorders

缺氧、炎症和微生物群之间的相互作用作为口腔癌前病变中恶性转化的指标

2025-08-080
OA
Predictive multi-omic signature in locally advanced laryngeal/hypopharyngeal (LH) squamous cell carcinoma (SCC) treated with induction chemotherapy (IC)

局部晚期喉/下咽(LH)鳞状细胞癌(SCC)诱导化疗(IC)的预测性多组学特征

2024-09-010
PRE
Safety of neoadjuvant PARP inhibitor and immunotherapy in locally advanced HPV-negative head and neck squamous cell carcinoma (PRIME H&N Study)

局部晚期HPV阴性头颈鳞状细胞癌中,新辅助PARP抑制剂联合免疫疗法的安全性(PRIME H&N研究)

2024-09-010
PRE
Is precision medicine the solution to improve organ preservation in laryngeal/hypopharyngeal cancer? A position paper by the Preserve Research Group
2024-08-062
OAAI
Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab
2024-01-301
OAAI
The association of cemiplimab plus sonidegib for synchronous cutaneous squamous cell carcinoma and basal cell carcinoma of the head and neck: Two case reports

cemiplimab加sonidegib与头颈部同步皮肤鳞状细胞癌和基底细胞癌的关系: 两例病例报告

2023-02-287
OAAI
Cytotoxic effects of targeted agent alone or with chemotherapy in the treatment of adenoid cystic carcinoma: a preclinical study

靶向药物单独或联合化疗治疗腺样囊性癌的细胞毒性作用: 一项临床前研究

2022-06-155
OAAI